KOROSTATIN Drug Patent Profile
✉ Email this page to a colleague
When do Korostatin patents expire, and when can generic versions of Korostatin launch?
Korostatin is a drug marketed by Holland Rantos and is included in one NDA.
The generic ingredient in KOROSTATIN is nystatin. There are eight drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the nystatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Korostatin
A generic version of KOROSTATIN was approved as nystatin by FOUGERA PHARMS on September 23rd, 1982.
Summary for KOROSTATIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 13 |
Patent Applications: | 4 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KOROSTATIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for KOROSTATIN
US Patents and Regulatory Information for KOROSTATIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Holland Rantos | KOROSTATIN | nystatin | TABLET;VAGINAL | 061718-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |